Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral develops devices for unmet medical needs. Sepsis occurs in 1.7M Americans/year causing 250K deaths, often caused by endotoxin. Our devices measure and remove endotoxin from the bloodstream. An FDA confirmatory trial is underway. Dialco, a Spectral sub, offers SAMI, a novel instrument for renal replacement, cleared by FDA. Dialco is seeking FDA approval for DIMI a unique home dialysis enabler. These devices have large commercial potential


TSX:EDT - Post by User

Comment by Domino55on Mar 15, 2022 4:25pm
96 Views
Post# 34516409

RE:RE:RE:RE:RE:Moratorium

RE:RE:RE:RE:RE:Moratorium Hmmmmmmmm- That's not Seto's fault. The company was valued at 32 cents. Obviously the board deemed it fair value. They must have run their own NPV calculations. Their numbers vary slightly from MMs but it's not an exact science.

Nobody has been willing to pay more than 40 cents a share for 8 months, despite managements best efforts to improve the share price! So they benefitted from the situation. In that context this was very fair dilution.
<< Previous
Bullboard Posts
Next >>